German Company in $3.9 Billion Deal to Buy US Biotech Firm SpringWorks
Favicon 
yubnub.news

German Company in $3.9 Billion Deal to Buy US Biotech Firm SpringWorks

Merck will acquire SpringWorks Therapeutics for $3.9 billion, aiming to strengthen its U.S. health care presence and expand rare tumor therapies worldwide.Merck KGaA, a German science and technology company,…